Jane K. Stock
Jane K. Stock publishes mostly in Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Cancer, Lipids, and Metabolism.
- World rank
- #1,591,165 of 7,710,434 ranked researchers
- Rank in Sweden
- #20,577 of 71,437
- Works
- 74
- Citations
- 9.3k
- Citations per work
- 125.9
What does Jane K. Stock research?
Jane K. Stock's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (9%), Economics, Econometrics and Finance (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4357.6%
- Medicine4357.6%
- Everything else1926.0%
- Life Sciences79.1%
- Social Sciences57.3%
- 1Surgery28% of their works
- 2Endocrinology, Diabetes and Metabolism15% of their works
- 3Cardiology and Cardiovascular Medicine10% of their works
- 4Cancer Research9% of their works
- 5Economics and Econometrics7% of their works
- 6Public Health, Environmental and Occupational Health5% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cancer, Lipids, and Metabolism
- Health Systems, Economic Evaluations, Quality of Life
- Antiplatelet Therapy and Cardiovascular Diseases
- Atherosclerosis and Cardiovascular Diseases
- Lipid metabolism and disorders
- Diet and metabolism studies
Which keywords describe Jane K. Stock's research?
The keywords of their largest research topics: Statins, Cardiovascular Disease Prevention, Cholesterol-lowering, Cholesterol, Atherosclerosis, Metabolic Syndrome, Cardiovascular Disease and Diabetes.
- Ketogenic Diet
- Lipoprotein Lipase
- ANGPTL3
- Aspirin
- Quality of Life
- Lipid Metabolism
- Diabetes
- Metabolic Syndrome
- Cholesterol
- Cardiovascular Disease Prevention
- Statins
- Cholesterol-lowering
- Atherosclerosis
- Cardiovascular Disease
- Fatty Acid Synthase
- Cost-effectiveness Analysis
- Inflammation
- Clopidogrel
- Immune Response
- Oxidized LDL
- Low-Carbohydrate Diet
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Statins752 topics
- Cardiovascular Disease Prevention551 topic
- Cholesterol-lowering551 topic
- Cholesterol492 topics
- Atherosclerosis413 topics
- Metabolic Syndrome403 topics
- Cardiovascular Disease291 topic
- Diabetes291 topic
- Fatty Acid Synthase201 topic
- Lipid Metabolism201 topic
- Cost-effectiveness Analysis121 topic
- Quality of Life121 topic
- Inflammation112 topics
- Aspirin71 topic
- Clopidogrel71 topic
- ANGPTL361 topic
- Immune Response61 topic
- Lipoprotein Lipase61 topic
- Oxidized LDL61 topic
- Ketogenic Diet51 topic
- Low-Carbohydrate Diet51 topic
Where does Jane K. Stock work?
Jane K. Stock's main affiliation in the publication record is European Atherosclerosis Society, Sweden.
How many publications and citations does Jane K. Stock have?
OpenAlex counts 74 works and 9,317 citations for Jane K. Stock, an h-index of 18, ranking #1,591,165 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jane K. Stock. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.